Skip to main content
. 2024 Jan 24;8(1):zrad148. doi: 10.1093/bjsopen/zrad148

Table 2.

Meta-analysis of POCT devices and subgroups

Analysis group Number of studies Number of patients Bias (g/l) Standard deviation of bias Between-study heterogeneity in bias (I2) 95% LOA (g/l)
Pulse Co-Ox 25 1110 2.3 1.15 0.57 (−25.2,29.8)
Pulse Co-Ox (funded) 8 423 2.1 1.17 0.98 (−31.0,35.1)
Pulse Co-Ox (unfunded) 17 687 2.2 1.14 0.18 (−22.1,26.6)
Pulse Co-Ox (blood loss > 1 litre) 5 305 −2.5 0.90 0.80 (−27.9,22.9)
HemoCue 10 525 −0.3 0.48 0.06 (−11.1,10.5)
HemoCue (arterial) 5 314 0.1 0.41 0.07 (−9.6,9.87)
HemoCue (capillary) 5 228 1.4 0.93 0.12 (−18.5,21.2)
HemoCue (venous) 2 90 −1.2 0.51 0.19 (−14.5,12.1)
iSTAT 6 146 −0.3 0.32 0.06 (−8.4,7.8)
Blood gas analyser 10 821 −2.6 0.51 0.32 (−17.8,12.7)
Low risk of bias (Pulse Co-Ox) 13 675 1.9 1.20 0.97 (−29.2,32.9)

POCT, point-of-care tests; LOA, limits of agreement.